Explore the vast range of titles available.

CPT¬ 2025 Professional Edition is the definitive American Medical Association (AMA)-authored resource to help health care professionals correctly report and bill medical procedures and services. Health care professionals want accurate reporting of services rendered and reimbursement. Payers want efficient claims processing. Correct reporting and billing of medical procedures and services begins with CPT¬ 2025 Professional Edition. Only the AMA, with the help of physicians and other experts in the health care community, creates and maintains the Current Procedural Terminology (CPT¬) code set. No other codebook has the accurate, complete official guidelines for the latest and current procedural terminology for procedures and services to help you code and report medical services and procedures properly. The AMA also takes the copyright protection of its content very seriously and is committed to providing the most effective anti-piracy efforts for its authors and readers, such as inclusion of the Amazon Anti Privacy Sticker and nonintrusive light-yellow dots on almost every page to reduce print reproduction in accordance with current copyright rules and laws. Recognizing that racism is a threat to the advancement of health equity and a barrier to appropriate medical care, as well as the power of images in contributing and limiting what bodies physicians, medical professionals, and students learn to see and define as normal and standard, the CPT 2025 Professional Edition will feature 29 diversity-related illustrations to counter a deep-seated, culturally, and systemically biased norm. These diversity-related images continue advancing inclusive and equitable representation of a diverse range of skin tones in our medical educational resources for everyone who uses our codebook in their daily work, practice, and education. Features and Benefits The CPT¬ 2025 Professional Edition codebook covers hundreds of code, guideline and text changes and features: CPT¬ Changes, CPT¬ Assistant, and Clinical Examples in Radiology citations — provides cross-referenced information to popular AMA resources that can enhance your understanding of the CPT code set. A comprehensive index — locate codes related to a specific procedure, service, anatomic site, condition, synonym, eponym or abbreviation quickly. Anatomical and procedural illustrations — help improve coding accuracy and understanding of the anatomy and services/procedures discussed. Overall codebook table of contents —enable a quick search of the entire codebook's content for quick access. Section table of contents — provide a useful tool to navigate effectively and quickly through each section's codes. Complete list of the additions, deletions and revisionsfor codes and code descriptors — provide a summary and quick reference of the 2025 changes in the codes without having to compare editions. Multiple appendices — offer additional information for modifiers; add-on codes; images of vascular families; re-sequenced codes, MAAAs and PLA services, digital medicine-services taxonomy; guidance for classifying various AI applications of AI for medical services and procedures; and all audio-only telemedicine CPT codes. Comprehensive E/M code selection tables — aid physicians and coders in assigning the most appropriate evaluation and management codes. Notes pages at the end of every code set section and subsection.

This insider's account of the work of the Indian Specific Claims Commission takes an unflinching look at the development and implementation of Indigenous claims policy from 1991 to 2009.

The aim of this project is to develop a stochastic simulation machine that generates individual claims histories of non-life insurance claims. This simulation machine is based on neural networks to incorporate individual claims feature information. We provide a fully calibrated stochastic scenario generator that is based on real non-life insurance data. This stochastic simulation machine allows everyone to simulate their own synthetic insurance portfolio of individual claims histories and back-test thier preferred claims reserving method.

This paper showcases the effectiveness of the discrete generalized Burr-Hatke distribution in analyzing insurance claims data, specifically focusing on scenarios with over-dispersed and zero-inflated claims. Key contributions include presenting foundational statistical theories with mathematical proofs to enrich the paper’s mathematical and statistical aspects. Through the application of this discrete distribution, the study conducted a thorough risk analysis across five diverse sets of insurance claims data, evaluating critical risk indicators at specified quantiles. These indicators provided detailed insights into potential losses across different risk levels, supporting effective risk management strategies. The research emphasizes the importance of selecting appropriate probability distributions when analyzing zero-inflated data, as commonly observed in insurance claims. The discrete distribution accommodated these unique data characteristics and facilitated a robust analysis of risk metrics, enhancing the accuracy of potential loss assessments and reducing associated uncertainties. Furthermore, the study highlights the practical relevance of the discrete distribution in addressing specific challenges inherent to insurance claims data. By leveraging this distribution, insurers and risk analysts can improve their risk modeling capabilities, leading to more informed decision-making and enhanced financial exposure management.

This study aimed to determine the prevalence of rheumatoid arthritis in the United States (US) adult insured population from 2004 to 2014. This was an observational, retrospective, cross-sectional study based on US administrative health insurance claims databases (Truven Health MarketScan ® Research database and IMS PharMetrics Plus database). Trends in RA prevalence focusing on the 10-year period covering January 1, 2004–December 31, 2014 were analyzed using a validated algorithm for the identification of RA. Prevalence rates in the databases were determined and age- and gender-adjusted rates were projected to the US population in 2014. Analysis of data from the two databases indicated that the RA prevalence rate in commercially insured adult US population ranged from 0.41 to 0.54% from 2004 to 2014. The prevalence varied substantially by gender and age in each year and increased gradually across the years for most subgroups. In 2014, out of 31,316,902 adult patients with continuous enrollment in the Truven Health MarketScan ® Research database, 157,634 (0.50%) patients met our criteria for RA. Similarly, out of 35,083,356 adult patients in the IMS PharMetrics Plus database, 139,300 (0.50%) patients met our criteria for RA. In 2014, the overall age-adjusted prevalence of RA ranged from 0.53 to 0.55% (0.29–0.31% for males and 0.73–0.78% for females). The prevalence of RA in the US appeared to increase during the period from 2004 to 2014, affecting a conservative estimate of 1.28–1.36 million adults in 2014.